OneMedNet's Liabilities Plummet 74%, RWD Revenue Surges 329% on AI Platform Momentum
ONMD has more than doubled off its 52-week low of $0.3.
Summary
OneMedNet announced significant improvements in its 2025 financials, including a 74% reduction in total liabilities from $19.7 million to $5.1 million, and a substantial decrease in shareholder deficit from $(16.0) million to $(3.0) million. The company also reported a 329% year-over-year increase in Real-World Data (RWD) revenue to $1.254 million, with Q4 2025 revenue surging to over $890,000. This news directly addresses the "substantial doubt about its ability to continue as a going concern" disclosed in the company's 10-K filing on March 30, 2026, providing a strong counter-narrative to those concerns. The dramatic reduction in liabilities and improved equity position significantly de-risks the company's financial outlook. The strong RWD revenue growth, driven by its AI-driven iRWD™ platform powered by Palantir Foundry, and the securing of new pilot customers with seven-figure subscription potential, indicate robust commercial momentum and future growth prospects. Investors will monitor the conversion of pilot customers into full contracts and the realization of the projected 4x platform growth by the end of 2026, as well as continued improvements in financial stability.
At the time of this announcement, ONMD was trading at $0.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $47.4M. The 52-week trading range was $0.30 to $4.22. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.